Pathways to Prevention (P2P)

Workshop Program

Workshop Agenda - Day 2

 

Day 2: October 31, 2018
8:30 a.m. to 1:00 p.m. Eastern Time

« See Day 1: October 30, 2018

 

Day 2

8:30 a.m.

Welcome

Albert Siu, M.D., M.S.P.H.


 

Key Question 3

Do drug holidays improve outcomes?

8:35 a.m.

Evidence-based Practice Center Presentation – Osteoporosis Drug Holidays: Benefits, Risk of Harms, and Effect Modifiers

Howard Fink, M.D., M.P.H.
Principal Investigator, Minnesota Evidence-based Practice Center
Minneapolis Veterans Affairs Health Care System


8:55 a.m.

Clinical Perspectives Regarding Drug Holidays Following Bisphosphonate Therapy

Dolores Shoback, M.D.
Professor of Medicine
University of California, San Francisco


9:15 a.m.

Tools to Guide Decisions Regarding Long-Term Treatment

Richard Eastell, M.D.
Professor and Head of the Academic Unit of Bone Metabolism
Director of the Mellanby Centre for Bone Research
The University of Sheffield, UK


9:35 a.m.

Discussion

Moderated by
Albert Siu, M.D., M.S.P.H.


 

Key Question 4, Part 2:

What patient and clinician factors impact the use of and adherence to osteoporotic drugs?

Overcoming Barriers to Drug Therapy


10:15 a.m.

Bridging the Gap: Research Knowledge to Practice

Paul D. Miller, M.D.
Distinguished Clinical Professor of Medicine, University of Colorado Health Sciences Center
Medical Director, Colorado Center for Bone Research
Panorama Orthopedics & Spine Center


10:30 a.m.

Recommendations for the Diagnosis and Management of Osteoporosis 

Marc C. Hochberg, M.D., M.P.H.
Professor of Medicine and Epidemiology and Public Health
Department of Medicine
University of Maryland School of Medicine


10:45 a.m.

Break


10:55 a.m.

Implementing Fracture Prevention Strategies: Patient and Provider Approaches

Kenneth Saag, M.D., M.Sc.
Jane Knight Lowe Professor of Medicine
Department of Medicine, Division of Clinical Immunology and Rheumatology
The University of Alabama at Birmingham


11:15 a.m.

Osteoporosis Improvement Across the Provider Spectrum: Implementation and Economics

Daniel H. Solomon, M.D., M.P.H.
Professor of Medicine
Department of Rheumatology
Brigham and Women's Hospital, Harvard Medical School


11:35 a.m.

Predicting Fractures with Surrogate Markers

Douglas C. Bauer, M.D.
Professor of Medicine and Epidemiology and Biostatistics
Division of General Internal Medicine
University of California, San Francisco


11:55 a.m.

Moving Forward with Fracture Prevention

Jane Cauley, Dr.P.H.
Distinguished Professor 
Department of Epidemiology
University of Pittsburgh


12:15 p.m.

Discussion

Moderated by
Albert Siu, M.D., M.S.P.H.


 

Conclusion

12:55 p.m.

Moving Forward Down the Pathway to Prevention

Marie Bernard, M.D.
Deputy Director
National Institute on Aging
National Institutes of Health


1:05 p.m.

Review of Next Steps, Instructions to Panel, and Adjourn

Albert Siu, M.D., M.S.P.H.


Attendees will be responsible for meals and/or light refreshments on their own, at their own cost. The government and/or government contractors are not involved in facilitating the provision of food and/or light refreshments.

« See Day 1: October 30, 2018

Workshop speakers
P2P Workshop Speakers
NIH/Andrew Propp
Last updated on June 5, 2020